Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
Titel:
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
Auteur:
Rivera, Fernando Romero, C. Jimenez-Fonseca, P. Izquierdo-Manuel, M. Salud, A. Martínez, E. Jorge, M. Arrazubi, V. Méndez, J. C. García-Alfonso, P. Reboredo, M. Barriuso, J. Muñoz-Unceta, N. Jimeno, R. López, C.